Our recent analysis shows how the total cost of care for prostate biopsy episodes varied substantially, based on whether the patient had complications.

Prior authorization presents benefits and challenges along with opportunities for improvement as plan sponsors aim to control costs and ensure access to appropriate drugs.

In view of the COVID-19 pandemic, this paper examines why, when, and how vaccines are used; highlights the vaccine development pathway; reviews previous experience with viral pandemics; and assesses ways payers can address COVID-19.

This report provides an independent review of the processes EmpiRx Health uses to calculate savings under the Clinical Savings Tracker component of its Clinical Care Management program.

This report evaluates the potential impact to provider reimbursement under alternative oncology payment structures and illustrates the inherent variabilities across patients using a simplified alternative oncology payment bundle for cancer drug treatments and related professional services.